ES

Stem Cell Therapy for Heart Failure


Table of Contents

Heart Failure and other Cardiovascular Diseases

Stem Cell Therapy for Heart Failure Ensuring Regenerative Proficiency

Cost of Stem Cell Therapy for Heart Disease

Stem Cell Therapy Financing

Giostar Stem Cell Therapy

Stem Cell Research References for Heart Conditions

Heart Failure and other Cardiovascular Diseases

Cardiopathy refers to any and all conditions of the heart. Degeneration of cardiac tissues is considered a major cause of mortality in the western world and is expected to be a greater problem in the forthcoming decades. Cardiac damage is associated with dysfunction and irreversible loss of cardiomyocytes. Stem cell therapy for ischemic heart failure is very promising approach in cardiovascular medicine. Initial trials have indicated the ability of cardiomyocytes to regenerate after myocardial injury. (1) Cardiovascular disease (CVD) accounts for more deaths globally than any other single disease. There are on average 1.5 million episodes of myocardial infarction (heart attack) each year in the United States alone with roughly one-third resulting in death. There is therefore a major need for developing new and effective strategies to promote cardiac repair. Cardiovascular disease is a broad term for problems with the heart and blood vessels. This condition occurs when fat and cholesterol build up on the walls of the blood vessel (artery). This buildup is called plaque. Over time, the plaque can narrow the blood vessels and cause problems throughout the body. If an artery becomes blocked, this can lead to a heart attack or stroke. (2)

The most common type of cardiovascular diseases are:

  • Coronary Artery Disease
  • Heart Failure
  • Heart attack
  • High Blood Pressure
  • Arrhythmia
  • Stroke

Stem cell therapy for heart failure ensuring regenerative proficiency 

The use of mesenchymal stem cells has shown to improve the cardiac structure and function, functional capacity and the patient's quality of life, thanks to the properties that stem cells have to reduce fibrosis in the heart. Stem cell therapy has demonstrated to benefit the heart by stimulating the natural regenerative response of the body. 

The use of mesenchymal stem cells has shown to improve the cardiac structure and function, functional capacity and the patient's quality of life, thanks to the properties that stem cells have to reduce fibrosis in the heart. Stem cell therapy has demonstrated to benefit the heart by stimulating the natural regenerative response of the body.  (3)

Administration of mesenchymal stem cells (MSCs) to diseased hearts improves cardiac function and reduces scar size. These effects occur via the stimulation of endogenous repair mechanisms, including regulation of immune responses, tissue perfusion, inhibition of fibrosis, and proliferation of resident cardiac cells. (4)

The last two decades have witnessed the development of novel regenerative medicine approaches for cardiovascular diseases. However, the ultimate goal of complete repair of the heart in response to damage has yet to be realized.

priscilla_video

ClickHerePatientsReviews

Cost of stem cell therapy for heart disease 

Stem cell therapy cost for Cardiovascular Disease, in Giostar Mexico, starts at $8,500.00 USD for one application (half-treatment). Pricing highly depends on the personalized protocol that the Medical Director determines based on each patient's condition. What may this include?

  • Transportation from hotel-clinic, clinic-hotel and airport-hotel as well as hotel-airport (mainly for our Clinics in Playa del Carmen and Guadalajara; our Clinic in Los Algodones, due to its proximity to the US-Mexico border crossing, we pick up patients on the border or at Yuma Airport and take them to our clinic or their hotel)
  • Lodging (available in our Clinic in Algodones) in Hotel Hacienda or Hotel Cielito Lindo
  • Oxygen Therapy
  • Body preparation – Nutritional IV Therapy
  • 1 - 10 billion exosomes (volume depends on Doctor's personal evaluation of each patient)
  • 1 - 4 stem cell vials (35 - 140 million stem cells)
  • Laboratory protocol by Dr. Anand (activation of the stem cells in order to direct them towards the affected tissue or organ)
  • Medical Consultation
  • Dietitian Follow up post-therapy
  • Preferential prices for future reinforcements/applications
  • Laboratory exams the previous day before the first application

Free Quote for Stem Cell Therapy at Giostar Mexico

If you are interested in receiving the benefits of stem cell therapy, you can fill out this contact form and we will give you a call or email you as soon as possible. You can also contact us directly to our US landline 619-866-6000.

Stem Cell Therapy Financing

 

Through United Medical Credit, our patients (exclusive for US citizens) may now receive up to $25,000.00 USD in credit for their treatment (note: price for therapy varies depending on the condition to be treated and a number of stem cells [vials] included). 

Giostar Stem Cell Therapy

Being part of the last three decades of innovative discoveries in the research-based area of regenerative medicine, Stem Cell Therapy promotes the reduction and stoppage of degenerative diseases or conditions, such as ALS, physical injuries and aging, bolstering the regeneration of damaged tissues, bodily processes and overall well-being.

Giostar Mexico specializes in medical tourism, receiving patients from all over the world. With the acquired understanding based on scientific research, we are able to provide personalized protocols to each patient. Through specialized allogenic mesenchymal adult stem cells, our regenerative therapy concentrates stem cells in the targeted area, organ or immune system, helping the body stop the progression of a disease or condition and begin regeneration. 

Why choose Giostar?

Thanks to a progressive legal framework in Mexico, Giostar can provide personalized therapy with intravenous and local applications otherwise legally unavailable in the United States and Canada. As everyone is unique, we develop personalized protocols for each patient. Although patients may share the same condition, we understand that similar symptoms does not necessarily mean same solution or treatment for everyone. Genetics, lifestyle and other circumstances can affect differently how patients respond to therapy.

It’s of utmost importance that you answer our health history form, this will determine two major factors:

  • Your eligibility for therapy
  • Your personalized protocol is developed according to your needs.

Stem cell therapy is a procedure in the regenerative medicine field. Regenerative medicine's ultimate goal is that our body regenerates itself. What stem cell therapy does in your body is slow down or stop the suffered deterioration and it can even regenerate damaged tissue and organs. That is why we ask our patients to fill out a Health Form, so our medical staff may first identify if stem cell therapy is actually an option for them, as well as allowing our medical team to understand each patient's specific health conditions.

Fill out this contact form and we will give you a call or email you as soon as possible. You can also contact us directly to our US landline 619-866-6000.

Stem cell research references for heart conditions

  1. Abdelwahid, E., Siminiak, T., Guarita-Souza, L. C., Teixeira de Carvalho, K. A., Gallo, P., Shim, W., & Condorelli, G. (2011). Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Current cardiology reviews, 7(3), 201–212. https://doi.org/10.2174/157340311798220502
  2. Toth PP, Shammas NW, Foreman B, Byrd JB, Brook RD. Cardiovascular disease. In: Rakel RE, Rakel DP, eds. Textbook of Family Medicine. 9th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 27.
  3. Yajun Guo, Yunsheng Yu, Shijun Hu, Yueqiu Chen and Zhenya Shen1. (2020). The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death & Disease, -, 10. 10/07/2021.
  4. Bagno et al., Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges, Molecular. Therapy (2018), https://doi.org/10.1016/j.ymthe.2018.05.009